Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria
In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applyin...
Gespeichert in:
Veröffentlicht in: | Journal of neurovirology 2012-06, Vol.18 (3), p.191-199 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 199 |
---|---|
container_issue | 3 |
container_start_page | 191 |
container_title | Journal of neurovirology |
container_volume | 18 |
creator | Royal, Walter Cherner, Mariana Carr, Jean Habib, Abdulrazaq G. Akomolafe, Abimbola Abimiku, Alashl’e. Charurat, Manhattan Farley, John Oluyemisi, Akinwande Mamadu, Ibrahim Johnson, Joyce Ellis, Ronald McCutchen, J. Allen Grant, Igor Blattner, William A. |
description | In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder. |
doi_str_mv | 10.1007/s13365-012-0097-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1069202709</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017617743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxiMEoqXwAFyQL0hcAv4Tx84RrQqtVMEFuFqOM1lNldiLnay0r8BTMyUL3BDywaNvfjMjfV9VvRT8reDcvCtCqVbXXMia887Up0fVpdDK1rJp1GOqlaautM1F9ayUe86FaqV9Wl1IqUm1_LL6sZswYvATG8Eva4bCfBzYIcOEM0afT6ws64Ckp5EdMacp7X_xIWWC_LJ1Iqw5hbSPuOARGM4Hj3mGuDA_p7hnN7ffaowjhAUGhnHAIw6rnwrV7BPuIaN_Xj0ZSYEX5_-q-vrh-svupr77_PF29_6uDo3mS910FrrBGt_2gg9BwNj3QC9IckOTOnA79uC7XlnZK6m8boXtgBttjTJSXVVvtr2HnL6vUBY3YwkwTT5CWosTvO0kl4Z3_4EK0wpjGkWo2NCQUykZRnfIOJN_BLmHtNyWlqO03ENa7kQzr87r136G4c_E73gIeH0GfCHPx-xjwPKX050VndLEyY0r1IrkprtPa47k4j-u_wRFobAk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017617743</pqid></control><display><type>article</type><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</creator><creatorcontrib>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</creatorcontrib><description>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</description><identifier>ISSN: 1355-0284</identifier><identifier>EISSN: 1538-2443</identifier><identifier>DOI: 10.1007/s13365-012-0097-y</identifier><identifier>PMID: 22528480</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adult ; Batteries ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cognition ; Cognition Disorders - epidemiology ; Cognition Disorders - etiology ; Cognition Disorders - virology ; Cognitive ability ; Corticotropin-releasing hormone ; Dementia disorders ; DNA Fingerprinting ; Female ; HIV Infections - complications ; HIV Infections - psychology ; HIV Seronegativity ; HIV Seropositivity ; HIV-1 - genetics ; HIV-1 - isolation & purification ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Immunology ; Infection ; Infectious Diseases ; Male ; Medical sciences ; Neurology ; Neuropsychological Tests ; Neurosciences ; Nigeria - epidemiology ; Research Design ; Risk Factors ; Task Performance and Analysis ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral diseases of the nervous system ; Viral Load ; Virology</subject><ispartof>Journal of neurovirology, 2012-06, Vol.18 (3), p.191-199</ispartof><rights>Journal of NeuroVirology, Inc. 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</citedby><cites>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13365-012-0097-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13365-012-0097-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25981935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22528480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Royal, Walter</creatorcontrib><creatorcontrib>Cherner, Mariana</creatorcontrib><creatorcontrib>Carr, Jean</creatorcontrib><creatorcontrib>Habib, Abdulrazaq G.</creatorcontrib><creatorcontrib>Akomolafe, Abimbola</creatorcontrib><creatorcontrib>Abimiku, Alashl’e.</creatorcontrib><creatorcontrib>Charurat, Manhattan</creatorcontrib><creatorcontrib>Farley, John</creatorcontrib><creatorcontrib>Oluyemisi, Akinwande</creatorcontrib><creatorcontrib>Mamadu, Ibrahim</creatorcontrib><creatorcontrib>Johnson, Joyce</creatorcontrib><creatorcontrib>Ellis, Ronald</creatorcontrib><creatorcontrib>McCutchen, J. Allen</creatorcontrib><creatorcontrib>Grant, Igor</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><title>Journal of neurovirology</title><addtitle>J. Neurovirol</addtitle><addtitle>J Neurovirol</addtitle><description>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</description><subject>Adult</subject><subject>Batteries</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cognition</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - virology</subject><subject>Cognitive ability</subject><subject>Corticotropin-releasing hormone</subject><subject>Dementia disorders</subject><subject>DNA Fingerprinting</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - psychology</subject><subject>HIV Seronegativity</subject><subject>HIV Seropositivity</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - isolation & purification</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunology</subject><subject>Infection</subject><subject>Infectious Diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Neurosciences</subject><subject>Nigeria - epidemiology</subject><subject>Research Design</subject><subject>Risk Factors</subject><subject>Task Performance and Analysis</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral diseases of the nervous system</subject><subject>Viral Load</subject><subject>Virology</subject><issn>1355-0284</issn><issn>1538-2443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQxiMEoqXwAFyQL0hcAv4Tx84RrQqtVMEFuFqOM1lNldiLnay0r8BTMyUL3BDywaNvfjMjfV9VvRT8reDcvCtCqVbXXMia887Up0fVpdDK1rJp1GOqlaautM1F9ayUe86FaqV9Wl1IqUm1_LL6sZswYvATG8Eva4bCfBzYIcOEM0afT6ws64Ckp5EdMacp7X_xIWWC_LJ1Iqw5hbSPuOARGM4Hj3mGuDA_p7hnN7ffaowjhAUGhnHAIw6rnwrV7BPuIaN_Xj0ZSYEX5_-q-vrh-svupr77_PF29_6uDo3mS910FrrBGt_2gg9BwNj3QC9IckOTOnA79uC7XlnZK6m8boXtgBttjTJSXVVvtr2HnL6vUBY3YwkwTT5CWosTvO0kl4Z3_4EK0wpjGkWo2NCQUykZRnfIOJN_BLmHtNyWlqO03ENa7kQzr87r136G4c_E73gIeH0GfCHPx-xjwPKX050VndLEyY0r1IrkprtPa47k4j-u_wRFobAk</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Royal, Walter</creator><creator>Cherner, Mariana</creator><creator>Carr, Jean</creator><creator>Habib, Abdulrazaq G.</creator><creator>Akomolafe, Abimbola</creator><creator>Abimiku, Alashl’e.</creator><creator>Charurat, Manhattan</creator><creator>Farley, John</creator><creator>Oluyemisi, Akinwande</creator><creator>Mamadu, Ibrahim</creator><creator>Johnson, Joyce</creator><creator>Ellis, Ronald</creator><creator>McCutchen, J. Allen</creator><creator>Grant, Igor</creator><creator>Blattner, William A.</creator><general>Springer US</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20120601</creationdate><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><author>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Batteries</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cognition</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - virology</topic><topic>Cognitive ability</topic><topic>Corticotropin-releasing hormone</topic><topic>Dementia disorders</topic><topic>DNA Fingerprinting</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - psychology</topic><topic>HIV Seronegativity</topic><topic>HIV Seropositivity</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - isolation & purification</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunology</topic><topic>Infection</topic><topic>Infectious Diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Neurosciences</topic><topic>Nigeria - epidemiology</topic><topic>Research Design</topic><topic>Risk Factors</topic><topic>Task Performance and Analysis</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral diseases of the nervous system</topic><topic>Viral Load</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Royal, Walter</creatorcontrib><creatorcontrib>Cherner, Mariana</creatorcontrib><creatorcontrib>Carr, Jean</creatorcontrib><creatorcontrib>Habib, Abdulrazaq G.</creatorcontrib><creatorcontrib>Akomolafe, Abimbola</creatorcontrib><creatorcontrib>Abimiku, Alashl’e.</creatorcontrib><creatorcontrib>Charurat, Manhattan</creatorcontrib><creatorcontrib>Farley, John</creatorcontrib><creatorcontrib>Oluyemisi, Akinwande</creatorcontrib><creatorcontrib>Mamadu, Ibrahim</creatorcontrib><creatorcontrib>Johnson, Joyce</creatorcontrib><creatorcontrib>Ellis, Ronald</creatorcontrib><creatorcontrib>McCutchen, J. Allen</creatorcontrib><creatorcontrib>Grant, Igor</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neurovirology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Royal, Walter</au><au>Cherner, Mariana</au><au>Carr, Jean</au><au>Habib, Abdulrazaq G.</au><au>Akomolafe, Abimbola</au><au>Abimiku, Alashl’e.</au><au>Charurat, Manhattan</au><au>Farley, John</au><au>Oluyemisi, Akinwande</au><au>Mamadu, Ibrahim</au><au>Johnson, Joyce</au><au>Ellis, Ronald</au><au>McCutchen, J. Allen</au><au>Grant, Igor</au><au>Blattner, William A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</atitle><jtitle>Journal of neurovirology</jtitle><stitle>J. Neurovirol</stitle><addtitle>J Neurovirol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>18</volume><issue>3</issue><spage>191</spage><epage>199</epage><pages>191-199</pages><issn>1355-0284</issn><eissn>1538-2443</eissn><abstract>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>22528480</pmid><doi>10.1007/s13365-012-0097-y</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-0284 |
ispartof | Journal of neurovirology, 2012-06, Vol.18 (3), p.191-199 |
issn | 1355-0284 1538-2443 |
language | eng |
recordid | cdi_proquest_miscellaneous_1069202709 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Adult Batteries Biological and medical sciences Biomedical and Life Sciences Biomedicine Cognition Cognition Disorders - epidemiology Cognition Disorders - etiology Cognition Disorders - virology Cognitive ability Corticotropin-releasing hormone Dementia disorders DNA Fingerprinting Female HIV Infections - complications HIV Infections - psychology HIV Seronegativity HIV Seropositivity HIV-1 - genetics HIV-1 - isolation & purification Human immunodeficiency virus 1 Human viral diseases Humans Immunology Infection Infectious Diseases Male Medical sciences Neurology Neuropsychological Tests Neurosciences Nigeria - epidemiology Research Design Risk Factors Task Performance and Analysis Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral diseases of the nervous system Viral Load Virology |
title | Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20and%20preliminary%20studies%20of%20virological%20correlates%20of%20neurocognitive%20impairment%20among%20HIV-infected%20individuals%20in%20Nigeria&rft.jtitle=Journal%20of%20neurovirology&rft.au=Royal,%20Walter&rft.date=2012-06-01&rft.volume=18&rft.issue=3&rft.spage=191&rft.epage=199&rft.pages=191-199&rft.issn=1355-0284&rft.eissn=1538-2443&rft_id=info:doi/10.1007/s13365-012-0097-y&rft_dat=%3Cproquest_cross%3E1017617743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017617743&rft_id=info:pmid/22528480&rfr_iscdi=true |